Literature DB >> 26098496

Differential diagnosis of diffuse alveolar haemorrhage in immunocompromised patients.

Dante Luiz Escuissato1, Danny Warszawiak, Edson Marchiori.   

Abstract

PURPOSE OF REVIEW: Diffuse alveolar haemorrhage (DAH) is a life-threatening medical emergency in immunocompromised and immunocompetent patients characterized by haemoptysis, anaemia, acute respiratory failure and diffuse pulmonary infiltrates on radiologic examination. This review describes DAH imaging features, causes and main differential diagnosis. RECENT
FINDINGS: In immunosuppressed patients, DAH occurs most frequently in haematologic neoplasms, after haematopoietic stem cell transplantation or solid organ transplantation, secondary to drug reaction or infection, and associated with AIDS. However, differential diagnoses of all of these conditions include several conditions with similar findings.
SUMMARY: Imaging patterns of DAH do not differ significantly from those of conditions included in the main differential diagnosis. The differential diagnosis depends on the patient's immunity status. In immunocompromised patients, infection and lung injury of other causes must be considered.

Entities:  

Mesh:

Year:  2015        PMID: 26098496     DOI: 10.1097/QCO.0000000000000181

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  7 in total

Review 1.  Diffuse Alveolar Hemorrhage in Autoimmune Diseases.

Authors:  Marco Ulises Martínez-Martínez; David Alejandro Herrera-van Oostdam; Carlos Abud-Mendoza
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

2.  Evaluation of Non-infectious Pulmonary Complications in Hematological Malignancies on MDCT: Decoding Imaging Markers.

Authors:  Rashmi Singh; Priyanka Naranje; Ashu Seith Bhalla; Smita Manchanda; Manoranjan Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-05       Impact factor: 0.915

3.  Legionella pneumonia associated with severe acute respiratory distress syndrome and diffuse alveolar hemorrhage - A rare association.

Authors:  Muhammad Kashif; Ravi Patel; Bharat Bajantri; Gilda Diaz-Fuentes
Journal:  Respir Med Case Rep       Date:  2017-03-14

4.  Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Authors:  Jongmin Lee; Chin Kook Rhee; Seok Chan Kim; Young Kyoon Kim; Hee Je Kim; Seok Lee; Seok-Goo Cho; Jong Wook Lee
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

5.  Leptospirosis manifested with severe pulmonary haemorrhagic syndrome successfully treated with venovenous extracorporeal membrane oxygenation.

Authors:  Jukkaphop Chaikajornwat; Pornpan Rattanajiajaroen; Nattachai Srisawat; Kamon Kawkitinarong
Journal:  BMJ Case Rep       Date:  2020-01-07

6.  The etiology, clinical profile, and outcome of diffuse alveolar hemorrhage in children: a ten-year single-center experience.

Authors:  Yuanyuan Qi; Libo Wang; Liling Qian; Xiaobo Zhang
Journal:  Transl Pediatr       Date:  2021-11

7.  Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.

Authors:  Fatma Keklik; Ezzideen Barjes Alrawi; Qing Cao; Nelli Bejanyan; Armin Rashidi; Aleksandr Lazaryan; Patrick Arndt; Erhan H Dincer; Veronika Bachanova; Erica D Warlick; Margaret L MacMillan; Mukta Arora; Jeffrey Miller; Claudio G Brunstein; Daniel J Weisdorf; Celalettin Ustun
Journal:  Haematologica       Date:  2018-08-03       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.